Opti Capital Management »

Halozyme Therapeutics shares owned by Opti Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Opti Capital Management from 13F filings

Historical chart of Opti Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Opti Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Opti Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $84B 73M 1148.53
2025-06-30 $71B 71M 996.99
2025-03-31 $64B 60M 1062.99
2024-12-31 $24B 25M 958.00